Descrição

Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels.

Figure 15

Diagram

Source Paper

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.

International journal of molecular sciences (2025)

PMID: 40564947

DOI: 10.3390/ijms26125486

Cite This Figure

![Figure 15: Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels." />
  <figcaption>Figure 15. Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>

Evidências Relacionadas

Berberine para Gut Dysbiosis

Nota D · 2 estudos